| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 06/28/2007 | US20070148253 Modified Release Formulation of Lithium Carbonate and Method for Preparation Thereof |
| 06/28/2007 | US20070148236 Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
| 06/28/2007 | US20070148216 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic |
| 06/28/2007 | US20070148178 Using beacizumab and antitumor agent as therapeutic treatment for mesothelioma |
| 06/28/2007 | US20070148177 Treatment with anti-vegf antibodies |
| 06/28/2007 | US20070148105 Compositions and methods comprising magnetic particles for health use |
| 06/28/2007 | US20070144515 Intermittent dosing of nitric oxide gas |
| 06/28/2007 | CA2634693A1 Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition |
| 06/28/2007 | CA2634140A1 Method and composition for treating and diagnosing restless legs syndrome |
| 06/28/2007 | CA2633099A1 Treatment of respiratory diseases |
| 06/28/2007 | CA2602042A1 Kit and composition of imidazole with enhanced bioavailability |
| 06/27/2007 | EP1800675A1 Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition |
| 06/27/2007 | EP1800549A2 Pharmaceutical kit for a preparation of a hydration salt with probiotic for babies |
| 06/27/2007 | EP1799237A1 Ointment for joining broken and fractured bones |
| 06/27/2007 | EP1799233A1 Clay purification method |
| 06/27/2007 | EP1799210A1 A guanylate cyclase stimulator and nitric oxide for treating bronchoconstriction and pulmonary vasconstriction |
| 06/27/2007 | EP1799204A1 Composition containing omega-3 fatty acids and omega-6 fatty acids |
| 06/27/2007 | EP1799192A2 Compositions and methods for treating excessive bleeding |
| 06/27/2007 | EP1799173A1 Treatment of spongiform encephalopathy using a hyperbaric environment |
| 06/27/2007 | EP0954340B1 Targeted combination immunotherapy of cancer |
| 06/27/2007 | CN1988923A Bone substitute compositions and method of use |
| 06/27/2007 | CN1988872A Cosmetic compositions comprising alkylene carbonates |
| 06/27/2007 | CN1985993A Compound preparation for enhancing memory |
| 06/27/2007 | CN1985991A Recipe and preparing process of drug addiction eliminating medicine |
| 06/27/2007 | CN1985983A Quick acting bone-knitting medicine and plaster and their preparing method |
| 06/27/2007 | CN1985964A Chinese medicine for treating recurrent mouth ulcer and its preparing method |
| 06/27/2007 | CN1985962A Medicine for treating facial neuritis and its preparing method |
| 06/27/2007 | CN1985945A Hot compress plaster for treating mastosis and its preparing method |
| 06/27/2007 | CN1985934A Medicine for treating hepatitis B and its preparing method |
| 06/27/2007 | CN1985903A Dead bone regenerating bolus for treating aseptic femoral head necrosis |
| 06/27/2007 | CN1985850A Oral medicine composition for replenishing Ca, Mg and Fe and its preparing method and use |
| 06/27/2007 | CN1985849A Medicine preparation for treating severe myasthenia |
| 06/27/2007 | CN1985848A Compound vitamin and mineral preparation for prenatal taking |
| 06/27/2007 | CN1322883C External-use medicine for treating prostatitis |
| 06/27/2007 | CN1322874C Medicine contg. zinc, honeysuckle, Radix scutellariae and forsynthia fruit |
| 06/27/2007 | CN1322868C Blood vessel care solution |
| 06/27/2007 | CN1322867C Hemostatic wound healing Dan |
| 06/27/2007 | CN1322849C Oral compositions which veil the salty taste of sodium bicarbonate |
| 06/26/2007 | US7235625 Administering phosphodiestarase inhibitors and melanocortin receptor antagonist: synergistic mixture |
| 06/26/2007 | US7235590 Administering treosulfan, busulfan, dimethyl busulfan, pentasulfan or hepsulfam to a person in a procedure that is not stem cell transplantation; for treatment of relapsing-remitting, primary progressive and in particular secondary progressive MS |
| 06/26/2007 | US7235264 Cerebral protection with a gas comprising xenon |
| 06/26/2007 | US7235256 administering a lactating animal during dry period, in a suitable form for peroral administration, a calcium-binding compound such as polysaccharide, effective to reduce the absorption of calcium from the drinking water and/or from the ration of such animal; natural calcium regulating mechanisms |
| 06/26/2007 | US7235255 a fibrinogen component; a thrombin component, anda corticosteroid such as betamethasone containing solution; improved fibrin sealant; |
| 06/26/2007 | CA2339356C Prostate formula |
| 06/22/2007 | CA2571276A1 Modified release formulation of lithium carbonate and method for the preparation thereof |
| 06/21/2007 | WO2007070637A2 Method of treating open wounds using hypochlorous acid |
| 06/21/2007 | WO2007070569A2 Composition and regimen for the treatment of epidermal herpetic lesions |
| 06/21/2007 | WO2007070463A2 Compositions, methods and kits for removing debris from an ocular area |
| 06/21/2007 | WO2007070110A2 Oxygen producing device for woundcare |
| 06/21/2007 | WO2007069934A1 Method of treating metabolic syndrome |
| 06/21/2007 | WO2007069933A1 Method for decreasing postprandial glucose excursion |
| 06/21/2007 | WO2007069932A1 Method for suppressing appetite and food intake |
| 06/21/2007 | WO2007068492A1 Medicinal composition with active ingredients and wound contact layer with a composition |
| 06/21/2007 | WO2007068490A1 Antimicrobial wound contact layer |
| 06/21/2007 | WO2006119300A3 Method of using oxidative reductive potential water solution in dental applications |
| 06/21/2007 | US20070142466 Photoreactive compounds and compositions |
| 06/21/2007 | US20070142421 Pharmaceutical Composition |
| 06/21/2007 | US20070142291 Methods for treating irritable bowel syndrome |
| 06/21/2007 | US20070142267 Methods for production of the oxidized glutathione composite with CIS-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 06/21/2007 | US20070141973 Microbiological Control in Poultry Processing |
| 06/21/2007 | US20070141177 Method for enhancing fertility |
| 06/21/2007 | US20070141176 Elemental sulfur as an oral or parentral medical product |
| 06/21/2007 | US20070141175 Chemotherapy adjuvant |
| 06/21/2007 | US20070141174 An oral formulation of cicletanine with carvedilol, lacidipine, or eplerenone; diabetes, diabetic complications, dyslipidemia, and cardiovascular and metabolic disorders; drug delivering stents |
| 06/21/2007 | US20070141173 Medicament comprising noble metal fine particles |
| 06/21/2007 | US20070141172 Method of treating bacterial hoof infections of sheep and cattle |
| 06/21/2007 | US20070141171 Novel composition and method for the treatment of hypertension |
| 06/21/2007 | US20070141170 Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision |
| 06/21/2007 | US20070141169 Homeopathic drug composition and methods of use thereof |
| 06/21/2007 | US20070141130 Wound or surgical dressing |
| 06/21/2007 | US20070141122 Nutritional composition and method of manufacture |
| 06/21/2007 | US20070141066 Method for Diagnosing, Prognosing and Treating Glioma |
| 06/21/2007 | US20070141058 Method of correcting immunopathological reactions and a medicament |
| 06/21/2007 | US20070141055 Methods and compositions for protein-hydroxy apatite complexes and their application in testing and modulating immunological system including a novel in vitro test for the detection of antibodies against calcium binding protein-hydroxy apatite complexes |
| 06/21/2007 | US20070141046 Activated carbon for medical use |
| 06/21/2007 | US20070141045 Use of adsorbent carbon microspheres for the treatment of irritable bowel syndrome |
| 06/21/2007 | US20070140988 Therapeutic agent for periodontal disease |
| 06/21/2007 | US20070140987 Promoting whole body health |
| 06/21/2007 | DE102005062160A1 Aktivkohle für die medizinische Verwendung Activated carbon for medical use |
| 06/21/2007 | CA2625640A1 Intravenous essential fatty acid emulsion |
| 06/20/2007 | EP1797891A1 Total enteral nutritious composition |
| 06/20/2007 | EP1797889A1 Activated carbon for medical use |
| 06/20/2007 | EP1796692A2 Trace elements |
| 06/20/2007 | EP1796691A1 Inorganic selenium for treatment of cancer |
| 06/20/2007 | EP1796641A1 A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
| 06/20/2007 | EP1185243B1 An anti-microbial silicone rubber composition and method making said composition |
| 06/20/2007 | CN1981858A Baicao gel for treating gynecologic inflammation |
| 06/20/2007 | CN1981834A Ointment for treating wound |
| 06/20/2007 | CN1981824A Medicinal liquor for treating rheumatosis |
| 06/20/2007 | CN1981806A Four-component prescription against urethral calculus |
| 06/20/2007 | CN1981780A Strontium compound for treatment of sub-dermal soft tissue pain |
| 06/20/2007 | CN1981773A Medicinal preparation for treating immune related diseases |
| 06/20/2007 | CN1321696C Composition and method for reducing side effects of indole-3-carbinol and derivatives |
| 06/20/2007 | CN1321646C Oral zinc reinforcing agent using hydrotalcite as carrier, its preparation and using method thereof |
| 06/20/2007 | CN1321633C Treatment of nail infections using NO generating compositions |
| 06/19/2007 | US7232579 Composition containing a marine-derived inorganic substance and chitin/chitosan, and method of producing the composition |
| 06/19/2007 | US7232577 Readily dispersible dietary fiber composition |
| 06/19/2007 | US7232571 Or Sporolactobacillus; also decreasing serum triglycerides, and increasing serum HDL; optionally along with an anticholesterol agent such as a statin, a bile sequestering compound, a fiber product capable of binding cholesterol, niacin or aspirin. |
| 06/19/2007 | CA2437468C Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus |
| 06/19/2007 | CA2166179C Use of a tnf-alpha antagonist in a cosmetic, pharmaceutical or skincare composition and composition thus obtained |